Related Experiment Video
Updated: Jun 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Tumour suppression by p53: a role for the DNA damage response?
1Biomedical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK. d.w.meek@dundee.ac.uk
Abstract:
Loss of p53 function occurs during the development of most, if not all, tumour types. This paves the way for genomic instability, tumour-associated changes in metabolism, insensitivity to apoptotic signals, invasiveness and motility. However, the nature of the causal link between early tumorigenic events and the induction of the p53-mediated checkpoints that constitute a barrier to tumour progression remains uncertain. This Review considers the role of the DNA damage response, which is activated during the early stages of tumour development, in mobilizing the tumour suppression function of p53. The relationship between these events and oncogene-induced p53 activation through the ARF pathway is also discussed.
Insights
Tumor suppressor p53 (also known as TP53) is crucial for preventing cancer. This review explores how DNA damage response and ARF pathway activate p53 to halt tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Loss of p53 function is a common event in tumor development.
- This loss contributes to genomic instability, altered metabolism, apoptosis resistance, and increased invasiveness.
- The precise link between early tumorigenesis and p53-mediated checkpoints is not fully understood.
Purpose of the Study:
- To review the role of the DNA damage response in activating p53's tumor suppressive functions.
- To discuss the connection between early tumor development and p53 activation via the ARF pathway.
Main Methods:
- Literature review focusing on DNA damage response pathways.
- Analysis of oncogene-induced p53 activation mechanisms.
- Discussion of the ARF pathway's role in p53 regulation.
Main Results:
- The DNA damage response is a key mechanism for activating p53 early in tumorigenesis.
- Oncogene activation can also trigger p53 through the ARF pathway, acting as a barrier to tumor growth.
- p53's tumor suppressive functions are critical for maintaining genomic stability and preventing malignant progression.
Conclusions:
- The DNA damage response and ARF pathway are critical in initiating p53-mediated tumor suppression.
- Understanding these pathways is essential for developing targeted cancer therapies.
- Restoring or enhancing p53 function holds therapeutic potential for various cancers.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...